4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-25-000035
Chief Executive Officer sold 12,619 shares at $1.59 ($20,102)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OConnell Daniel Joseph Chief Executive Officer | 2025-01-21 | Sale 10b5-1 | −12,619 | $1.59 | $20,102 | 667,488 | D |
| Open-market sales · 12,619 sh · avg $1.59 · $20,102 | |||||||
Loading xslF345X05/wk-form4_1737670677.xml…